» Authors » John Marshall

John Marshall

Explore the profile of John Marshall including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 539
Citations 25247
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
An S, Teo K, McConnell M, Marshall J, Galloway C, Squirrell D
Prog Retin Eye Res . 2025 Mar; :101352. PMID: 40086660
Recent developments in artificial intelligence (AI) have seen a proliferation of algorithms that are now capable of predicting a range of systemic diseases from retinal images. Unlike traditional retinal disease...
2.
Marshall J, Manella H
Am J Med Qual . 2025 Mar; PMID: 40051086
A novel volunteer program was implemented in the adult emergency department waiting room to combat declining patient satisfaction, a crucial quality metric impacting everything from hospital reimbursement to clinical outcomes....
3.
Chen X, Kroke B, Ni J, Munoz C, Appleman M, Jacobs B, et al.
Exp Neurol . 2025 Jan; 386:115151. PMID: 39832663
Hypoxic-ischemic (HI) brain injury is a common neurological problem in neonates. The postsynaptic density protein-95 (PSD-95) is an excitatory synaptic scaffolding protein that regulates synaptic function, and represents a potential...
4.
Takaoka A, Johnstone J, Lauzier F, Heels-Ansdell D, Davis M, Zytaruk N, et al.
Trials . 2024 Dec; 25(1):851. PMID: 39731129
Background: Understanding site-related factors that influence enrolment within multicenter randomized controlled trials (RCT) may help reduce trial delays and cost over-runs and prevent early trial discontinuation. In this analysis of...
5.
Stanga P, Reinstein D, Valentin Bravo F, Saladino A, Eduardo Stanga S, Reinstein U, et al.
Retina . 2024 Dec; PMID: 39693577
Purpose: Propose new terminology and evaluate the effectiveness of Therapeutic Refractive Vitrectomy (TRV) for selective removal of vitreous floaters and opacities (VFO) utilizing Standardized Kinetic Anatomical Functional Testing of VFO...
6.
Tikhe C, Issiaka S, Dong Y, Kefi M, Tavadia M, Bilgo E, et al.
Sci Adv . 2024 Dec; 10(49):eads3658. PMID: 39630892
Vector mosquito control is an integral part of malaria control. The global emergence of insecticide resistance in malaria-transmitting has become an impediment and has created an urgent need for novel...
7.
Lewis O, Lloyd J, Ferry J, Macfarlane A, Womack J, El-Boghdadly K, et al.
Anaesthesia . 2024 Nov; 80(2):170-178. PMID: 39584463
Introduction: Regional anaesthesia provides important clinical benefits to patients but is underutilised. A barrier to widespread adoption may be the focus of regional anaesthesia research on novel techniques rather than...
8.
Hsiehchen D, Elliott A, Xiu J, Seeber A, El-Deiry W, Antonarakis E, et al.
Cancer Cell . 2024 Nov; 42(12):1985-1987. PMID: 39577419
Analysis of 27,810 patients with advanced cancers treated with anti-PD-1/L1 therapies shows that immune gene signatures or immune cell infiltration is not universally associated with mutation burden or long-term survivors...
9.
Daneman N, Rishu A, Pinto R, Rogers B, Rogers B, Shehabi Y, et al.
N Engl J Med . 2024 Nov; 392(11):1065-1078. PMID: 39565030
Background: Bloodstream infections are associated with substantial morbidity and mortality. Early, appropriate antibiotic therapy is important, but the duration of treatment is uncertain. Methods: In a multicenter, noninferiority trial, we...
10.
Huie E, Yang X, Rioult-Pedotti M, Tran K, Monsen E, Hansen K, et al.
Neuropsychopharmacology . 2024 Nov; PMID: 39511336
Angelman syndrome (AS) is a rare genetic neurodevelopmental disorder with profoundly debilitating symptoms with no FDA-approved cure or therapeutic. Brain-derived neurotrophic factor (BDNF), and its receptor tropomyosin receptor kinase B...